Trials / Completed
CompletedNCT02175316
Enhanced External Counterpulsation on Delayed Onset Muscle Soreness
Effects of Enhanced External Counterpulsation on Delayed Onset Muscle Soreness, a Pilot Study
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 18 (actual)
- Sponsor
- David Grant U.S. Air Force Medical Center · Federal
- Sex
- All
- Age
- 25 Years – 59 Years
- Healthy volunteers
- Accepted
Summary
This study will evaluate the effects of Enhanced External Counterpulsation on delayed onset muscle soreness. The primary outcomes will be duration of delayed onset muscle soreness, WBC count, CRP count, CPK count, and pain tolerance.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Enhanced External Counterpulsation | Enhanced External Counterpulsation |
Timeline
- Start date
- 2014-04-01
- Primary completion
- 2017-07-25
- Completion
- 2017-09-06
- First posted
- 2014-06-26
- Last updated
- 2020-04-22
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT02175316. Inclusion in this directory is not an endorsement.